Global and India Metformin Hydrochloride Market Insights, Forecast to 2027

Metformin Hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
Asia-Pacific is the largest market with about 60% revenue market share. Followed by Europe, accounting for about 17% revenue market share.
The key players are Wanbury, USV, Exemed Pharmaceuticals, Vistin Pharma, Aarti Drugs, Farmhispania Group, Harman Finochem, Shijiazhuang Polee Pharmaceutical, Keyuan Pharmaceutical, CR Double-Crane, Shouguang Fukang Pharmaceutical etc. USV is the largest manufacturer with about 26% revenue market share.

Market Analysis and Insights: Global and India Metformin Hydrochloride Market
This report focuses on global and India Metformin Hydrochloride market.
In 2020, the global Metformin Hydrochloride market size was US$ 276.5 million and it is expected to reach US$ 405.6 million by the end of 2027, with a CAGR of 5.5% during 2021-2027. In India the Metformin Hydrochloride market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Metformin Hydrochloride Scope and Market Size
Metformin Hydrochloride market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Metformin Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For India market, this report focuses on the Metformin Hydrochloride market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in India.

Segment by Type
Metformin HCL
Metformin DC
Others

Segment by Application
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others Form

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Wanbury
USV
Exemed Pharmaceuticals
Vistin Pharma
Aarti Drugs
Farmhispania Group
Harman Finochem
Shijiazhuang Polee Pharmaceutical
Keyuan Pharmaceutical
CR Double-Crane
Shouguang Fukang Pharmaceutical